Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.

Verified February 2011 by Chinese Academy of Medical Sciences.
Recruitment status was: Not yet recruiting

Sponsor:

Information provided by:

Chinese Academy of Medical Sciences

ClinicalTrials.gov Identifier:

NCT01300689

First received: February 22, 2011

Last updated: NA

Last verified: February 2011

History: No changes posted

Purpose

This is a observational study aims to assess anal and genital human papillomavirus (HPV) infection status among men who have sex with men (MSM) in China, and their knowledge and attitude about HPV vaccine.

Condition
HPV Infection HIV Infection Syphilis


Study Type:	Observational
Study Design:	Observational Model: Ecologic or Community Time Perspective: Cross-Sectional

Resource links provided by NLM:

Genetic and Rare Diseases Information Center resources: Treponema Infection

U.S. FDA Resources

Further study details as provided by Chinese Academy of Medical Sciences:


Estimated Enrollment:	3000
Study Start Date:	July 2011

Eligibility


Ages Eligible for Study:	18 Years and older (Adult, Senior)
Sexes Eligible for Study:	Male
Accepts Healthy Volunteers:	Yes
Sampling Method:	Probability Sample

Study Population

A total of 3,000 eligible men who have sex with men (MSM) with 300 from each city will be enrolled from ten cities (BeiJing, ShangHai, TianJin, ChongQing, GuangZhou, ZhengZhou, Harbin, ShenYang, ChengDu, and KunMing) by the local CDCs and non-government MSM organizations

Criteria

Inclusion Criteria:

≥ 18 years old;
Ever had homosexual behaviors in the past 12 months;
Willing to take tests for HIV/HPV infection;
Physically able and willing to provide written informed consent.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01300689

Contacts


Contact: XiangWei Li, MD	86-10-67855012	xiangweili@ipbcams.ac.cn

Locations


China, Beijing
Institute of Pathogen Biology (IPB)	Not yet recruiting
Beijing, Beijing, China, 100730
Contact: Yu Yang, MD wolfson@ipbcams.ac.cn
Principal Investigator: Lei Gao, Ph. D.

Sponsors and Collaborators

Chinese Academy of Medical Sciences

Investigators


Principal Investigator:	Lei Gao, Ph.D.	Institute of Pathogen Biology (IPB), CAMS&PUMC

More Information

Publications:

Gao L, Zhou F, Li X, Yang Y, Ruan Y, Jin Q. Anal HPV infection in HIV-positive men who have sex with men from China. PLoS One. 2010 Dec 6;5(12):e15256. doi: 10.1371/journal.pone.0015256.


Responsible Party:	Lei Gao, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College
ClinicalTrials.gov Identifier:	NCT01300689 History of Changes
Other Study ID Numbers:	HPV and MSM in China
Study First Received:	February 22, 2011
Last Updated:	February 22, 2011

Keywords provided by Chinese Academy of Medical Sciences:


HPV MSM Vaccine China

Additional relevant MeSH terms:


Infection Communicable Diseases HIV Infections Papillomavirus Infections Syphilis Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases	Immunologic Deficiency Syndromes Immune System Diseases DNA Virus Infections Tumor Virus Infections Treponemal Infections Gram-Negative Bacterial Infections Bacterial Infections Sexually Transmitted Diseases, Bacterial Spirochaetales Infections Genital Diseases, Male Genital Diseases, Female

ClinicalTrials.gov processed this record on September 21, 2017

To Top